Thanks for your analysis.
ROW sales I think wouldn't be at anywhere near the $ value per patient as USA. Do you really think ROW sales would be 3 rimes U S figure?
The other more positive impact on SP of sustainable sales is that the earnings per share will be multiplied by the market PE for similar companies. This could be a multiple 10, 20 even 30. What do you believe the PE would be for PYC when at peak sustainable earnings?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.28 |
Change
0.040(3.23%) |
Mkt cap ! $743.6M | |||
| Open | High | Low | Value | Volume |
| $1.25 | $1.28 | $1.25 | $71.05K | 56.40K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 444 | $1.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 28000 | 1 |
View Market Depth
| Last trade - 13.48pm 25/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |